Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M BERGER

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Pharmacology|January 1, 1973
The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agentF M Berger, H M Bates, W Diamantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1975
Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteriaA Lamensans, L Chedid, E Lederer, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 9, 2013
Transfusion of leukocyte-depleted RBCs is independently associated with increased morbidity after pediatric cardiac surgeryMartin C J Kneyber, Femke Grotenhuis, Rolf F M Berger, et al.
Infection and Immunity|June 1, 1973
Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opacaA Adam, R Ciorbaru, J F Petit, et al.
Developments in Biological Standardization|January 1, 1992
Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilisV Houba, F M Berger, C A Dinarello, et al.
Fortschritte Der Medizin. Originalien|March 5, 2003
[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office]J Kohler, M W Riepe, K Jendroska, et al.
MMW Fortschritte Der Medizin|January 21, 2003
[Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration]J Kohler, M W Riepe, K Jendroska, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Pharmacology|January 1, 1973
The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agentF M Berger, H M Bates, W Diamantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1975
Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteriaA Lamensans, L Chedid, E Lederer, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 9, 2013
Transfusion of leukocyte-depleted RBCs is independently associated with increased morbidity after pediatric cardiac surgeryMartin C J Kneyber, Femke Grotenhuis, Rolf F M Berger, et al.
Infection and Immunity|June 1, 1973
Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opacaA Adam, R Ciorbaru, J F Petit, et al.
Developments in Biological Standardization|January 1, 1992
Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilisV Houba, F M Berger, C A Dinarello, et al.
Fortschritte Der Medizin. Originalien|March 5, 2003
[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office]J Kohler, M W Riepe, K Jendroska, et al.
MMW Fortschritte Der Medizin|January 21, 2003
[Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration]J Kohler, M W Riepe, K Jendroska, et al.
Pageof 4